This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mycovia Pharmaceuticals, Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Eduard Hartmann: Innovator in Antifungal Compounds
Introduction
Eduard Hartmann is a notable inventor based in Rodenbach, Germany. He has made significant contributions to the field of antifungal agents, holding two patents that showcase his innovative approach to compound preparation.
Latest Patents
Hartmann's latest patents focus on a process for preparing compounds that are useful as antifungal agents. The inventions specifically relate to compounds 5 or 5*, and their mixtures, aiming to provide new methodologies for preparing compounds 7, 7*, and 11, 11*, along with their substituted derivatives. These advancements are crucial in the ongoing battle against fungal infections.
Career Highlights
Eduard Hartmann is currently associated with Mycovia Pharmaceuticals, Inc., where he applies his expertise in developing antifungal solutions. His work is instrumental in advancing the pharmaceutical industry’s capabilities in treating fungal infections.
Collaborations
Throughout his career, Hartmann has collaborated with notable colleagues, including David Dale Wirth and Christopher M. Yates. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Eduard Hartmann's contributions to antifungal compound processes highlight his role as a significant inventor in the pharmaceutical industry. His patents reflect a commitment to improving health outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile